153 related articles for article (PubMed ID: 38674198)
21. Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma.
Chang PE; Tan CK
Indian J Med Sci; 2009 May; 63(5):202-3. PubMed ID: 19584492
[No Abstract] [Full Text] [Related]
22. Reduced expression of low-density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia.
Sohda T; Iwata K; Kitamura Y; Suzuki N; Takeyama Y; Irie M; Anan A; Nakane H; Yoshikane M; Watanabe H; Sakisaka S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e153-6. PubMed ID: 17784865
[TBL] [Abstract][Full Text] [Related]
23. [Clinical features of urological malignancies with paraneoplastic syndromes].
Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ
Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathological study of juvenile hepatocellular carcinoma].
Furusawa A; Unoura M; Notsumata K; Morioka T; Hayakawa K; Matsushita E; Kobayashi K; Hattori N; Makino H; Fukuoka K
Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2765-72. PubMed ID: 2483177
[TBL] [Abstract][Full Text] [Related]
25. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations.
Iyer JG; Parvathaneni K; Bhatia S; Tarabadkar ES; Blom A; Doumani R; McKenzie J; Asgari MM; Nghiem P
J Am Acad Dermatol; 2016 Sep; 75(3):541-547. PubMed ID: 27177440
[TBL] [Abstract][Full Text] [Related]
26. Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma.
Ding GX; Feng CC; Song NH; Fang ZJ; Xia GW; Jiang HW; Hua LX; Ding Q
Urol Oncol; 2013 Nov; 31(8):1820-5. PubMed ID: 22534085
[TBL] [Abstract][Full Text] [Related]
27. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
28. Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma.
Moldovan T; Boynton D; Kuperus J; Parker J; Noyes SL; Brede CM; Tobert CM; Lane BR
Urol Oncol; 2023 Sep; 41(9):392.e11-392.e17. PubMed ID: 37537025
[TBL] [Abstract][Full Text] [Related]
29. 3-Hydroxyl-3-methylglutaryl-coenzyme A reductase is up regulated in hepatocellular carcinoma associated with paraneoplastic hypercholesterolemia.
Sohda T; Iwata K; Hirano G; Sakurai K; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sakisaka S
Med Mol Morphol; 2013 Dec; 46(4):239-42. PubMed ID: 23549978
[TBL] [Abstract][Full Text] [Related]
30. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic syndromes and oncological outcomes in renal cancer.
Ikuerowo SO; Ojewuyi OO; Omisanjo OA; Abolarinwa AA; Bioku MJ; Doherty AF
Niger J Clin Pract; 2019 Sep; 22(9):1271-1275. PubMed ID: 31489865
[TBL] [Abstract][Full Text] [Related]
32. [Abnormal glucose metabolism--paraneoplastic syndromes--statistics and etiological mechanism].
Takeda K
Nihon Rinsho; 1980 Dec; 38(12):4498-505. PubMed ID: 6265664
[No Abstract] [Full Text] [Related]
33. Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: A propensity score matching analysis.
Su CW; Fang KC; Lee RC; Liu CA; Chen PH; Lee PC; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
J Formos Med Assoc; 2020 Feb; 119(2):610-620. PubMed ID: 31542334
[TBL] [Abstract][Full Text] [Related]
34. [Incidence of paraneoplastic syndromes in a series of 204 hepatocellular carcinomas].
Burette A; Van Gossum M; Laurent E; Bourgeois N; Adler M; Deltenre M
Acta Gastroenterol Belg; 1985; 48(4):352-69. PubMed ID: 3008483
[No Abstract] [Full Text] [Related]
35. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
36. Thrombocytosis and hepatocellular carcinoma.
Carr BI; Guerra V
Dig Dis Sci; 2013 Jun; 58(6):1790-6. PubMed ID: 23314854
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area.
Kim JH; Choi MS; Lee H; Kim DY; Lee JH; Koh KC; Yoo BC; Paik SW; Rhee JC
J Gastroenterol Hepatol; 2006 Mar; 21(3):588-94. PubMed ID: 16638104
[TBL] [Abstract][Full Text] [Related]
38. [Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer].
Somogyi A; Herold M; Lohinszky J; Harsányi L; Herold Z
Orv Hetil; 2019 Dec; 160(51):2012-2020. PubMed ID: 31838859
[TBL] [Abstract][Full Text] [Related]
39. Longer survival in female than male with hepatocellular carcinoma.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
J Gastroenterol Hepatol; 2003 Mar; 18(3):267-72. PubMed ID: 12603526
[TBL] [Abstract][Full Text] [Related]
40. Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.
Manson G; Maria ATJ; Poizeau F; Danlos FX; Kostine M; Brosseau S; Aspeslagh S; Du Rusquec P; Roger M; Pallix-Guyot M; Ruivard M; Dousset L; Grignou L; Psimaras D; Pluvy J; Quéré G; Grados F; Duval F; Bourdain F; Maigne G; Perrin J; Godbert B; Taifas BI; Forestier A; Voisin AL; Martin-Romano P; Baldini C; Marabelle A; Massard C; Honnorat J; Lambotte O; Michot JM
J Immunother Cancer; 2019 Dec; 7(1):337. PubMed ID: 31796119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
